{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:17:49Z","timestamp":1788247069291,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"DOI":"10.1007\/s11882-026-01288-z","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:18:17Z","timestamp":1788239897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Updates on Immunologic Responses to Aeroallergen Immunotherapy Since the 2011 US Practice Parameters on Allergen Immunotherapy"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-5331","authenticated-orcid":false,"given":"D\u00e9sir\u00e9e","family":"Larenas-Linnemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2541-7075","authenticated-orcid":false,"given":"Dennis","family":"Ledford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"1 Suppl","key":"1288_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","volume":"127","author":"L Cox","year":"2011","unstructured":"Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1\u201355.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1288_CR2","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jaci.2020.02.026","volume":"145","author":"JM Leyva-Castillo","year":"2020","unstructured":"Leyva-Castillo JM, Galand C, Mashiko S, Bissonnette R, McGurk A, Ziegler SF, et al. ILC2 activation by keratinocyte-derived IL-25 drives IL-13 production at sites of allergic skin inflammation. J Allergy Clin Immunol. 2020;145(6):1606\u201314. e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1288_CR3","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1111\/all.14526","volume":"75","author":"H Hong","year":"2020","unstructured":"Hong H, Liao S, Chen F, Yang Q, Wang DY. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75(11):2794\u2013804.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1165\/rcmb.2012-0304OC","volume":"49","author":"H Kouzaki","year":"2013","unstructured":"Kouzaki H, Tojima I, Kita H, Shimizu T. Transcription of interleukin-25 and extracellular release of the protein is regulated by allergen proteases in airway epithelial cells. Am J Respir Cell Mol Biol. 2013;49(5):741\u201350.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"1288_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/mi.2015.110","volume":"9","author":"UM Zissler","year":"2016","unstructured":"Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, et al. Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways. Mucosal Immunol. 2016;9(4):917\u201326.","journal-title":"Mucosal Immunol"},{"issue":"5","key":"1288_CR6","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.jaci.2023.06.025","volume":"152","author":"MC Altman","year":"2023","unstructured":"Altman MC, Segnitz RM, Larson D, Jayavelu ND, Smith MT, Patel S, et al. Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy. J Allergy Clin Immunol. 2023;152(5):1247\u201360.","journal-title":"J Allergy Clin Immunol"},{"key":"1288_CR7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.5414\/ALX02300E","volume":"6","author":"P Satitsuksanoa","year":"2022","unstructured":"Satitsuksanoa P, Angelina A, Palomares O, Akdis M. Mechanisms in AIT: Insights 2021. Allergol Select. 2022;6:259\u201366.","journal-title":"Allergol Select"},{"issue":"1","key":"1288_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12887-022-03788-z","volume":"23","author":"X Wang","year":"2023","unstructured":"Wang X, Shen Y, Hong S, Kang H, Ke X. Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis. BMC Pediatr. 2023;23(1):13.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1288_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jaci.2015.12.1325","volume":"138","author":"V Lombardi","year":"2016","unstructured":"Lombardi V, Beuraud C, Neukirch C, Moussu H, Morizur L, Horiot S, et al. Circulating innate lymphoid cells are differentially regulated in allergic and nonallergic subjects. J Allergy Clin Immunol. 2016;138(1):305\u20138.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1288_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.immuni.2020.12.013","volume":"54","author":"K Golebski","year":"2021","unstructured":"Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. 2021;54(2):291\u2013307. e7.","journal-title":"Immunity"},{"issue":"6","key":"1288_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4168\/aair.2018.10.6.662","volume":"10","author":"W Mitthamsiri","year":"2018","unstructured":"Mitthamsiri W, Pradubpongsa P, Sangasapaviliya A, Boonpiyathad T. Decreased CRTH2 Expression and Response to Allergen Re-stimulation on Innate Lymphoid Cells in Patients With Allergen-Specific Immunotherapy. Allergy Asthma Immunol Res. 2018;10(6):662\u201374.","journal-title":"Allergy Asthma Immunol Res"},{"key":"1288_CR12","doi-asserted-by":"crossref","unstructured":"Gueguen C, Bouley J, Moussu H, Luce S, Duchateau M, Chamot-Rooke J et al. Changes in markers associated with dendritic cells driving the differentiation of either T2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy. J Allergy Clin Immunol. 2015.","DOI":"10.1016\/j.jaci.2015.09.015"},{"issue":"3","key":"1288_CR13","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/mi.2016.87","volume":"10","author":"L Mascarell","year":"2017","unstructured":"Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10(3):695\u2013704.","journal-title":"Mucosal Immunol"},{"issue":"4","key":"1288_CR14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","volume":"129","author":"A Zimmer","year":"2012","unstructured":"Zimmer A, Bouley J, Le Mignon M, Pliquet E, Horiot S, Turfkruyer M, et al. A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol. 2012;129(4):1020\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"1288_CR15","doi-asserted-by":"publisher","first-page":"916491","DOI":"10.3389\/fimmu.2022.916491","volume":"13","author":"J Zimmermann","year":"2022","unstructured":"Zimmermann J, Goretzki A, Meier C, Wolfheimer S, Lin YJ, Rainer H, et al. Modulation of dendritic cell metabolism by an MPLA-adjuvanted allergen product for specific immunotherapy. Front Immunol. 2022;13:916491.","journal-title":"Front Immunol"},{"issue":"2","key":"1288_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jaci.2015.09.015","volume":"137","author":"C Gueguen","year":"2016","unstructured":"Gueguen C, Bouley J, Moussu H, Luce S, Duchateau M, Chamot-Rooke J, et al. Changes in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy. J Allergy Clin Immunol. 2016;137(2):545\u201358.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1288_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2022.05.025","volume":"150","author":"L Laoubi","year":"2022","unstructured":"Laoubi L, Lacoffrette M, Valsesia S, Lenief V, Guironnet-Paquet A, Mosnier A, et al. Epicutaneous allergen immunotherapy induces a profound and selective modulation in skin dendritic-cell subsets. J Allergy Clin Immunol. 2022;150(5):1194\u2013208.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1288_CR18","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/all.14756","volume":"76","author":"UM Zissler","year":"2021","unstructured":"Zissler UM, Jakwerth CA, Guerth F, Lewitan L, Rothkirch S, Davidovic M, et al. Allergen-specific immunotherapy induces the suppressive secretoglobin 1A1 in cells of the lower airways. Allergy. 2021;76(8):2461\u201374.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1111\/all.14264","volume":"76","author":"JM Schmid","year":"2021","unstructured":"Schmid JM, Wurtzen PA, Siddhuraj P, Jogdand P, Petersen CG, Dahl R, et al. Basophil sensitivity reflects long-term clinical outcome of subcutaneous immunotherapy in grass pollen-allergic patients. Allergy. 2021;76(5):1528\u201338.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR20","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jaci.2012.04.039","volume":"130","author":"N Novak","year":"2012","unstructured":"Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, et al. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol. 2012;130(5):1153\u20138. e2.","journal-title":"J Allergy Clin Immunol"},{"key":"1288_CR21","doi-asserted-by":"publisher","first-page":"603050","DOI":"10.3389\/fimmu.2020.603050","volume":"11","author":"C Kanagaratham","year":"2020","unstructured":"Kanagaratham C, El Ansari YS, Lewis OL, Oettgen HC. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy. Front Immunol. 2020;11:603050.","journal-title":"Front Immunol"},{"issue":"4","key":"1288_CR22","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.5415\/apallergy.2022.12.e45","volume":"12","author":"JF Lopez","year":"2022","unstructured":"Lopez JF, Bel Imam M, Satitsuksanoa P, Lems S, Yang M, Hwang YK, et al. Mechanisms and biomarkers of successful allergen-specific immunotherapy. Asia Pac Allergy. 2022;12(4):e45.","journal-title":"Asia Pac Allergy"},{"issue":"8","key":"1288_CR23","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1111\/all.14218","volume":"75","author":"H Lou","year":"2020","unstructured":"Lou H, Huang Y, Ouyang Y, Zhang Y, Xi L, Chu X, et al. Artemisia annua-sublingual immunotherapy for seasonal allergic rhinitis: A randomized controlled trial. Allergy. 2020;75(8):2026\u201336.","journal-title":"Allergy"},{"issue":"6","key":"1288_CR24","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s41385-018-0038-z","volume":"11","author":"P Bacher","year":"2018","unstructured":"Bacher P, Scheffold A. Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy. Mucosal Immunol. 2018;11(6):1537\u201350.","journal-title":"Mucosal Immunol"},{"key":"1288_CR25","doi-asserted-by":"crossref","unstructured":"Wambre E, Bajzik V, DeLong JH, O\u2019Brien K, Nguyen QA, Speake C et al. A phenotypically and functionally distinct human T(H)2 cell subpopulation is associated with allergic disorders. Sci Transl Med. 2017;9(401):1\u201321.","DOI":"10.1126\/scitranslmed.aam9171"},{"key":"1288_CR26","doi-asserted-by":"publisher","unstructured":"Suhrkamp I, Scheffold A, Heine G. T-cell subsets in allergy and tolerance induction. Eur J Immunol. 2023;10:e2249983. https:\/\/doi.org\/10.1002\/eji.202249983","DOI":"10.1002\/eji.202249983"},{"issue":"5","key":"1288_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.jaci.2017.09.041","volume":"141","author":"A Renand","year":"2018","unstructured":"Renand A, Shamji MH, Harris KM, Qin T, Wambre E, Scadding GW, et al. Synchronous immune alterations mirror clinical response during allergen immunotherapy. J Allergy Clin Immunol. 2018;141(5):1750\u2013e601.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1288_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12865-023-00556-1","volume":"24","author":"K Fan","year":"2023","unstructured":"Fan K, Zhou S, Jin L, Tan S, Lai J, Zhang Z, et al. Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis. BMC Immunol. 2023;24(1):19.","journal-title":"BMC Immunol"},{"issue":"9","key":"1288_CR29","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1111\/all.13436","volume":"73","author":"F Ihara","year":"2018","unstructured":"Ihara F, Sakurai D, Yonekura S, Iinuma T, Yagi R, Sakurai T, et al. Identification of specifically reduced Th2 cell subsets in allergic rhinitis patients after sublingual immunotherapy. Allergy. 2018;73(9):1823\u201332.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR30","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jaci.2008.01.072","volume":"121","author":"JN Francis","year":"2008","unstructured":"Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, et al. Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol. 2008;121(5):1120\u2013e52.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1288_CR31","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1365-2222.2010.03462.x","volume":"40","author":"GW Scadding","year":"2010","unstructured":"Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, Lima MT, et al. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Clin Exp Allergy. 2010;40(4):598\u2013606.","journal-title":"Clin Exp Allergy"},{"key":"1288_CR32","doi-asserted-by":"publisher","first-page":"981126","DOI":"10.3389\/falgy.2022.981126","volume":"3","author":"M Matsuda","year":"2022","unstructured":"Matsuda M, Terada T, Kitatani K, Kawata R, Nabe T. Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy. Front Allergy. 2022;3:981126.","journal-title":"Front Allergy"},{"issue":"3","key":"1288_CR33","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jaci.2018.06.041","volume":"143","author":"MH Shamji","year":"2019","unstructured":"Shamji MH, Layhadi JA, Achkova D, Kouser L, Perera-Webb A, Couto-Francisco NC, et al. Role of IL-35 in sublingual allergen immunotherapy. J Allergy Clin Immunol. 2019;143(3):1131\u201342. e4.","journal-title":"J Allergy Clin Immunol"},{"key":"1288_CR34","doi-asserted-by":"crossref","unstructured":"Durham SR, Shamji MH. Allergen immunotherapy: past, present and future. Nat Rev Immunol. 2023;23(5):317\u201328.","DOI":"10.1038\/s41577-022-00786-1"},{"issue":"2","key":"1288_CR35","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaci.2020.10.035","volume":"147","author":"H Sharif","year":"2021","unstructured":"Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, et al. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;147(2):663\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1288_CR36","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jaip.2021.03.029","volume":"9","author":"MH Shamji","year":"2021","unstructured":"Shamji MH, Layhadi JA, Sharif H, Penagos M, Durham SR. Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens. J allergy Clin Immunol Pract. 2021;9(5):1769\u201378.","journal-title":"J allergy Clin Immunol Pract"},{"issue":"7","key":"1288_CR37","doi-asserted-by":"publisher","first-page":"100803","DOI":"10.1016\/j.waojou.2023.100803","volume":"16","author":"Y Zeng","year":"2023","unstructured":"Zeng Y, Xiao H, Gao S, Li J, Yang C, Zeng Q, et al. Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis. World Allergy Organ J. 2023;16(7):100803.","journal-title":"World Allergy Organ J"},{"issue":"3","key":"1288_CR38","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/all.15512","volume":"78","author":"D Lozano-Ojalvo","year":"2023","unstructured":"Lozano-Ojalvo D, Tyler SR, Aranda CJ, Wang J, Sicherer S, Sampson HA, et al. Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans. Allergy. 2023;78(3):697\u2013713.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR39","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/all.13684","volume":"74","author":"T Boonpiyathad","year":"2019","unstructured":"Boonpiyathad T, Sokolowska M, Morita H, Ruckert B, Kast JI, Wawrzyniak M, et al. Der p 1-specific regulatory T-cell response during house dust mite allergen immunotherapy. Allergy. 2019;74(5):976\u201385.","journal-title":"Allergy"},{"issue":"4","key":"1288_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","volume":"131","author":"W van de Veen","year":"2013","unstructured":"van de Veen W, Stanic B, Yaman G, Wawrzyniak M, Sollner S, Akdis DG, et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol. 2013;131(4):1204\u201312.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1288_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaci.2019.11.046","volume":"146","author":"I Hoof","year":"2020","unstructured":"Hoof I, Schulten V, Layhadi JA, Stranzl T, Christensen LH, de la Herrera S, et al. Allergen-specific IgG(+) memory B cells are temporally linked to IgE memory responses. J Allergy Clin Immunol. 2020;146(1):180\u201391.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1288_CR42","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/all.15529","volume":"78","author":"CI McKenzie","year":"2023","unstructured":"McKenzie CI, Varese N, Aui PM, Reinwald S, Wines BD, Hogarth PM, et al. RNA sequencing of single allergen-specific memory B cells after grass pollen immunotherapy: Two unique cell fates and CD29 as a biomarker for treatment effect. Allergy. 2023;78(3):822\u201335.","journal-title":"Allergy"},{"issue":"4","key":"1288_CR43","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaci.2021.03.030","volume":"148","author":"MH Shamji","year":"2021","unstructured":"Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, et al. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;148(4):1061\u2013e7111.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1288_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/all.13553","volume":"74","author":"R Varona","year":"2019","unstructured":"Varona R, Ramos T, Escribese MM, Jimeno L, Galan A, Wurtzen PA, et al. Persistent regulatory T-cell response 2 years after 3 years of grass tablet SLIT: Links to reduced eosinophil counts, sIgE levels, and clinical benefit. Allergy. 2019;74(2):349\u201360.","journal-title":"Allergy"},{"issue":"2","key":"1288_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","volume":"127","author":"LK James","year":"2011","unstructured":"James LK, Shamji MH, Walker SM, Wilson DR, Wachholz PA, Francis JN, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 2011;127(2):509\u2013e161.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1288_CR46","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1111\/all.16083","volume":"79","author":"I Eguiluz-Gracia","year":"2024","unstructured":"Eguiluz-Gracia I, Parkin RV, Layhadi JA, Palmer E, Meng X, Zhu R, et al. Nasal allergen-neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis. Allergy. 2024;79(8):2197\u2013206.","journal-title":"Allergy"},{"issue":"5","key":"1288_CR47","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.jaci.2017.09.054","volume":"142","author":"L Zha","year":"2018","unstructured":"Zha L, Leoratti FMS, He L, Mohsen MO, Cragg M, Storni F, et al. An unexpected protective role of low-affinity allergen-specific IgG through the inhibitory receptor FcgammaRIIb. J Allergy Clin Immunol. 2018;142(5):1529\u201336. e6.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1288_CR48","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jaci.2019.02.023","volume":"144","author":"H Sharif","year":"2019","unstructured":"Sharif H, Singh I, Kouser L, Mosges R, Bonny MA, Karamani A, et al. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2019;144(3):738\u201349.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1288_CR49","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/cea.14432","volume":"54","author":"S Starchenka","year":"2024","unstructured":"Starchenka S, Oluwayi K, Heath M, Armfield O, Shamji M, Layhadi J, et al. Peripheral blood mononuclear cell transcriptome profile in a clinical trial with subcutaneous, grass pollen allergoid immunotherapy. Clin Exp Allergy. 2024;54(2):130\u201342.","journal-title":"Clin Exp Allergy"},{"issue":"Pt A","key":"1288_CR50","doi-asserted-by":"publisher","first-page":"110822","DOI":"10.1016\/j.intimp.2023.110822","volume":"124","author":"S Cao","year":"2023","unstructured":"Cao S, Wu H, Niu Y, Wang L, Wang F. Circulating exosomal has-miR-24-3p and has-miR-128-3p reflect early efficacy of sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 2023;124(Pt A):110822.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"1288_CR51","first-page":"3607","volume":"22","author":"J Bai","year":"2020","unstructured":"Bai J, Zhong JY, Liao W, Hu R, Chen L, Wu XJ, et al. iTRAQ\u2013based proteomic analysis reveals potential regulatory networks in dust mite\u2013related asthma treated with subcutaneous allergen immunotherapy. Mol Med Rep. 2020;22(5):3607\u201320.","journal-title":"Mol Med Rep"},{"issue":"9","key":"1288_CR52","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/all.14265","volume":"75","author":"AC Jones","year":"2020","unstructured":"Jones AC, Anderson D, Troy NM, Mallon D, Hartmann R, Serralha M, et al. Rewiring of gene networks underlying mite allergen-induced CD4\u2009+\u2009Th-cell responses during immunotherapy. Allergy. 2020;75(9):2330\u201341.","journal-title":"Allergy"},{"key":"1288_CR53","doi-asserted-by":"publisher","unstructured":"DeBerg HA, Baloh CH, DeGottardi Q, Hou J, Johansson A, Newell E et al. Differential effects of subcutaneous and sublingual immunotherapy on Timothy grass-specific Th2 CD4(+) T cell subsets. J Allergy Clin Immunol. 2026. https:\/\/doi.org\/10.1016\/j.jaci.2026.02.026","DOI":"10.1016\/j.jaci.2026.02.026"},{"key":"1288_CR54","doi-asserted-by":"crossref","unstructured":"Magnan A, Nicolas JF, Caimmi D, Vocanson M, Haddad T, Colas L et al. Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy. J Pers Med. 2023;13(2):1\u201316.","DOI":"10.3390\/jpm13020324"},{"key":"1288_CR55","doi-asserted-by":"publisher","first-page":"971155","DOI":"10.3389\/falgy.2022.971155","volume":"3","author":"M Thetis-Soulie","year":"2022","unstructured":"Thetis-Soulie M, Hosotte M, Grozelier I, Baillez C, Scurati S, Mercier V. The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes. Front Allergy. 2022;3:971155.","journal-title":"Front Allergy"},{"issue":"5","key":"1288_CR56","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/j.jaci.2020.08.042","volume":"147","author":"A Eljaszewicz","year":"2021","unstructured":"Eljaszewicz A, Ruchti F, Radzikowska U, Globinska A, Boonpiyathad T, Gschwend A, et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. J Allergy Clin Immunol. 2021;147(5):1865\u201377.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1288_CR57","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.jaci.2022.06.024","volume":"150","author":"T Iinuma","year":"2022","unstructured":"Iinuma T, Kiuchi M, Hirahara K, Kurita J, Kokubo K, Yagyu H, et al. Single-cell immunoprofiling after immunotherapy for allergic rhinitis reveals functional suppression of pathogenic T(H)2 cells and clonal conversion. J Allergy Clin Immunol. 2022;150(4):850\u201360. e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1288_CR58","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.4049\/jimmunol.160.7.3555","volume":"160","author":"P Jeannin","year":"1998","unstructured":"Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998;160(7):3555\u201361.","journal-title":"J Immunol"},{"issue":"10","key":"1288_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s12098-018-2703-3","volume":"85","author":"Y Wang","year":"2018","unstructured":"Wang Y, Li C, Xu Y, Xu D, Yang G, Liao F, et al. Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis. Indian J Pediatr. 2018;85(10):872\u20136.","journal-title":"Indian J Pediatr"},{"issue":"2","key":"1288_CR60","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.job.2019.02.001","volume":"61","author":"Y Tanaka","year":"2019","unstructured":"Tanaka Y, Fukumoto S, Sugawara S. Mechanisms underlying the induction of regulatory T cells by sublingual immunotherapy. J Oral Biosci. 2019;61(2):73\u20137.","journal-title":"J Oral Biosci"},{"issue":"2","key":"1288_CR61","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaci.2020.10.035","volume":"147","author":"H Sharif","year":"2021","unstructured":"Sharif H, Acharya S, Dhondalay GKR, Varricchi G, Krasner-Macleod S, Laisuan W, et al. Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;147(2):663\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1288_CR62","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jaci.2019.02.008","volume":"144","author":"Y Yao","year":"2019","unstructured":"Yao Y, Wang ZC, Wang N, Zhou PC, Chen CL, Song J, et al. Allergen immunotherapy improves defective follicular regulatory T cells in patients with allergic rhinitis. J Allergy Clin Immunol. 2019;144(1):118\u201328.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1288_CR63","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.jaci.2019.02.023","volume":"144","author":"H Sharif","year":"2019","unstructured":"Sharif H, Singh I, Kouser L, Mosges R, Bonny MA, Karamani A, et al. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2019;144(3):738\u201349.","journal-title":"J Allergy Clin Immunol"},{"key":"1288_CR64","doi-asserted-by":"crossref","unstructured":"Navas A, Ruiz-Leon B, Serrano P, Marti M, Espinazo ML, Blanco N et al. Natural and Induced Tolerance to Hymenoptera Venom: A Single Mechanism? Toxins (Basel). 2022;14(7).","DOI":"10.3390\/toxins14070426"},{"issue":"3","key":"1288_CR65","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/iid3.314","volume":"8","author":"K Otsuka","year":"2020","unstructured":"Otsuka K, Otsuka H, Matsune S, Okubo K. Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy. Immun Inflamm Dis. 2020;8(3):333\u201341.","journal-title":"Immun Inflamm Dis"},{"issue":"5","key":"1288_CR66","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.anai.2012.03.009","volume":"108","author":"DE Larenas-Linnemann","year":"2012","unstructured":"Larenas-Linnemann DE, Gupta P, Mithani S, Ponda P. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration. Ann Allergy Asthma Immunol. 2012;108(5):373\u2013e83.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"1288_CR67","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJM199908123410702","volume":"341","author":"SR Durham","year":"1999","unstructured":"Durham SR, Walker SM, Varga EM, Jacobson MR, O\u2019Brien F, Noble W, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341(7):468\u201375.","journal-title":"N Engl J Med"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-026-01288-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-026-01288-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:04:01Z","timestamp":1788246241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-026-01288-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s11882-026-01288-z","relation":{},"ISSN":["1534-6315"],"issn-type":[{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":1,"name":"Ethics","label":"Human and Animal Rights and Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Larenas Linnemann reports personal fees from ALK, Armstrong, Astrazeneca national and global, Chiesi, GSK national and global, Megalabs Ecuador, Naos, Novartis, Pfizer, Sanofi, Siegfried, Syneos Health, grants from Abbvie, Lilly, Sanofi, Astrazeneca, Pfizer, Novartis, GSK, Chiesi, Biopharma, outside the submitted work; and Editor in chief of Immune System (Karger); Member of international committee ACAAI; Subgroup chair of allergen immunotherapy Practice parameter update JTF AAAAI\/ACAAI 2026; Member of allergen immunotherapy committee AAAAI; Chair of allergen immunotherapy committee CMICA; Member of prevention task force EAACI. Dr Ledford reports personal fees from AstraZeneca, CSL Behring, GSK, Sanofi, Regeneron not related to the submitted work. He is associate editor of Annals of Allergy Asthma and Immunology, contributor to UpToDate, co-chair of the AAAAI\/ACAAI Joint Task Force on Practice Parameters, and a work group member of the JTFPP allergy immunotherapy practice parameter 4th update 2026.","order":2,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"47"}}